Two-dimensional radiotherapy and docetaxel in treatment of stage III non-small cell lung carcinoma: no good survival due to radiation pneumonitis.
Dinçbas
Fazilet Oner
FO
Atalar
Banu
B
Koca
Sedat
S
D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D000077143:Docetaxel; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D017564:Radiation Pneumonitis / Q000209:etiology*; D012307:Risk Factors; D043823:Taxoids / Q000009:adverse effects* / Q000627:therapeutic use*; D013997:Time Factors
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel